Transdermal Skin Patches Market Value to Exceed of USD 11.5 Bn by 2031, rising at a 4.6% CAGR: TMR Report

The global𝐭𝐫𝐚𝐧𝐬𝐝𝐞𝐫𝐦𝐚𝐥 𝐬𝐤𝐢𝐧 𝐩𝐚𝐭𝐜𝐡𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭, valued at US$ 7.7 billion in 2022, is on a trajectory of robust growth, projected to achieve a CAGR of 4.6% from 2023 to 2031, surpassing US$ 11.5 billion by 2031.

This surge is primarily propelled by intensive research and development efforts aimed at advancing transdermal patch technology, coupled with the increasing recognition of the advantages offered by transdermal medicines over traditional oral and ingested medications. The appeal of transdermal patches lies in their convenience, non-invasiveness, and ability to maintain consistent drug concentrations in plasma, making them a preferred drug delivery method.

Factors such as the rising prevalence of pain-related disorders and the global burden of tobacco use further bolster market growth. Manufacturers are actively pursuing collaborations, acquisitions, and innovative product launches to expand their market presence.

Their focus on developing smart, dissolving/biodegradable, high-loading/release, 3D-printed, and wearable patches underscores the industry's commitment to innovation and meeting evolving consumer needs. With continued advancements in drug delivery through skin patches, the market presents significant opportunities for growth and expansion.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2245&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

Hisamitsu Pharmaceutical Co., Inc., Viatris Inc., Nitto Denko Corporation, Novartis AG, Luye Pharma Group, Samyang Holdings Corporation, Teikoku Pharma, AdhexPharma, Sparsha Pharma International Pvt. Ltd., and Gedeon Richter Plc. 

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞

Reservoir
Drug-in-Adhesive
Single Layer
Multilayer
Microneedle
Matrix
Others (Vapor, etc.)

𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Pain Management
Hormonal Disorders
Smoking Reduction and Cessation Aid
Neurological Disorders
Cardiovascular Disorders
Others (Motion Sickness, Overactive Bladder, etc.)

𝐒𝐚𝐥𝐞𝐬 𝐓𝐲𝐩𝐞

Prescription
Over-the-Counter (OTC)

𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In April 2023, researchers at MIT University developed a wearable patch that enables painless skin patch delivery. The patch utilizes painless ultrasonic waves to create tiny channels, allowing drugs to pass through the tough outer layer of the skin. This innovative approach holds the potential for delivering treatments for various skin conditions. This patch can also be adapted for delivering muscle relaxants, hormones, and other drugs.

In September 2022, Corium, Inc. introduced a transdermal patch for the treatment of Alzheimer's disease. The patch, known as ADLARITY (donepezil transdermal system), is now available for prescription use in the U.S. This patch is specifically designed for patients with mild, moderate, or severe dementia of the Alzheimer's type. ADLARITY received approval from the FDA, making it the first and only patch with once-weekly formulations of either 5 mg/day or 10 mg/day.

𝐏𝐥𝐚𝐜𝐞 𝐚𝐧 𝐎𝐫𝐝𝐞𝐫 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.transparencymarketresearch.com/checkout.php?rep_id=2245<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬:

𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

Increasing prevalence of chronic diseases.
Growing demand for non-invasive drug delivery methods.
Technological advancements in transdermal patch technology.
Rising geriatric population.

𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬:

Regulatory hurdles and approval processes.
Limited efficacy for certain drug classes.
Competition from alternative drug delivery methods.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

Integration of smart technology in transdermal patches for real-time monitoring.
Expansion of product portfolios by key market players.
Growing focus on pediatric and geriatric-friendly patches.
Strategic collaborations and partnerships among industry stakeholders.

𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

The future of the transdermal skin patches market looks promising, with continued advancements in technology, expanding applications in various therapeutic areas, and a shift towards personalized medicine. Key market players are expected to focus on innovation, research, and strategic alliances to gain a competitive edge in the evolving landscape.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Market dynamics, including drivers, challenges, and trends.
Comprehensive analysis of market segments and sub-segments.
Regional analysis highlighting growth prospects in key geographies.
Competitive landscape, including market share analysis and strategic initiatives.
Recent developments and regulatory updates shaping the market.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐒𝐦𝐚𝐥𝐥 𝐂𝐞𝐥𝐥 𝐋𝐮𝐧𝐠 𝐂𝐚𝐧𝐜𝐞𝐫 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭-
https://www.globenewswire.com/news-release/2023/05/05/2662743/0/en/Small-Cell-Lung-Cancer-Therapeutics-Market-Value-to-Exceed-of-USD-12-9-Bn-by-2031-rising-at-a-11-9-CAGR-TMR-Report.html

𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/05/2662659/0/en/Transformer-Market-is-Expected-to-Ascend-at-Around-5-7-CAGR-Exceeding-a-Valuation-of-Around-US-48-11-Billion-by-2031-TMR-Report.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com      
Email:  sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.